Relative Value Assessment: Characterizing the Benefit of Oncology Therapies Through Diverse Survival Metrics From a US Perspective

ClinicoEconomics and Outcomes Research - New Zealand
doi 10.2147/ceor.s177343
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Php181 - Health Technology Assessment of Oncology Therapies in Spain and Italy: Key Metrics and Considerations

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn303 - Assessing the Value of Novel Immuno-Oncology (I-O) Therapies: How Consistent Is the Health Technology Assessment (Hta) Bodies' Consideration of the Survival Benefit in the Absence of Long-Term Data?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn26 - Assessing the Potential Value of an Innovative Oncology Therapy From the Health Technology Assessment (Hta) Perspective: Marrying Clinical Value Frameworks With Economic Assessment Methodology

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Endoderm From a Diverse Perspective

Development (Cambridge)
Developmental BiologyMolecular Biology
2018English

Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Diverse IT Metrics

IT Professional
HardwareComputer Science ApplicationsArchitectureSoftware
2012English

Value Assessment of E-Government Service From Municipality Perspective

2017English

MTE07.01 From Radiation Oncology Perspective

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Characterizing the Seabed: A Geoscience Perspective

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy